Vaccine rollout key to Pharmaniaga’s earnings


A lorry belonging to Pharmaniaga Lifescience Sdn Bhd at the Puchong Utama industrial park. It transported the COVID-19 vaccine Sinovac from the KLIA on Feb 27. - Bernamapic

PETALING JAYA: Pharmaniaga Bhd’s share price has been on an uptrend over the past month as it prepares to roll out the Sinovac Covid-19 vaccine from its facilities by end June.

Yesterday, the share price hit an intra-day high of RM4.50 – the highest in three months. It closed the day 9.93% higher to RM4.43.

Limited time offer:
Just RM5 per month.

Monthly Plan

RM13.90/month
RM5/month

Billed as RM5/month for the 1st 6 months then RM13.90 thereafters.

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In Business News

Trade showing remains on upward trajectory
Maxis pledges full support to government’s 5G delivery model
Fajarbaru Builder secures RM13mil job
MKH Oil Palm IPO oversubscribed
Making the Malaysian startup pitch
The pros and cons of earned wage access
Making every load lighter
Batik, chips and tech in the fabric of society
How Sin-Kung leveraged air cargo for its success
Domestic office-sector REITs stay cautious

Others Also Read